Reduced Dose Intensities of Doxorubicin in Elderly Patients with DLBCL in Rituximab Era-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Reduced Dose Intensities of Doxorubicin in Elderly Patients with DLBCL in Rituximab Era

Published:2016-01-15 Issue:1 Volume:48 Page:304-311
ISSN:1598-2998
Container-title:Cancer Research and Treatment
language:en
Short-container-title:Cancer Res Treat

Author:

Ha Hyerim,Keam Bhumsuk,Kim Tae Min,Jeon Yoon Kyung,Lee Se-Hoon,Kim Dong-Wan,Kim Chul Woo,Heo Dae Seog

Funder

Innovative Research Institute for Cell Therapy, Republic of Korea

Publisher

Korean Cancer Association

Subject

Cancer Research,Oncology

Link

http://e-crt.org/upload/pdf/crt-2014-339.pdf

Reference24 articles.

1. Lymphoma incidence patterns by WHO subtype in the United States, 1992-2001

2. Long-term outcome of patients in the LNH-98.5 trial, the first randomized study comparing rituximab-CHOP to standard CHOP chemotherapy in DLBCL patients: a study by the Groupe d'Etudes des Lymphomes de l'Adulte

3. Is lymphoma occurring in the elderly the same disease?

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Economic burden in treated Japanese patients with relapsed/refractory large B-cell lymphoma;Future Oncology;2021-11

2. Anthracycline chemotherapy‐mediated vascular dysfunction as a model of accelerated vascular aging;Aging and Cancer;2021-06

3. Impact of R-CHOP dose intensity on survival outcomes in diffuse large B-cell lymphoma: a systematic review;Blood Advances;2021-05-07

4. Treatment approaches for older and oldest patients with diffuse large B-cell lymphoma – Use of non-R-CHOP alternative therapies and impact of comorbidities on treatment choices and outcome: A Humedica database retrospective cohort analysis, 2007–2015;Journal of Geriatric Oncology;2020-01

5. Maintaining Dose Intensity of Adjuvant Chemotherapy in Older Patients With Breast Cancer;Clinical Breast Cancer;2018-10

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3